Nerve and Muscle Center of Texas

Houston, Texas 77099

3 studies enrolling now · 30 studies all time

What they study most

AChR Myasthenia Gravis, ALS, Active Idiopathic Inflammatory Myopathy, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Antiphospholipid Syndrome (APS), Antisynthetase Syndrome, Behçet's Syndrome (BS), Bullous Pemphigoid (BP), Dermatomyositis, Dermatomyositis (DM), Diabetes Mellitus, Type 1

Studies at this site

• Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) — Recruiting now
• A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG. — Recruiting now
• A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. — Completed
• A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy — Enrolling by invitation
• Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
• A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis — Running, not enrolling
• A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) — Running, not enrolling
• Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis — Running, not enrolling
• Sporadic Inclusion Body Myositis Natural History Study — Running, not enrolling
• Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
• EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA — Completed
• EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy — Completed
• A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis — Completed
• A Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain — Stopped early
• A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy — Completed
• Phase 3 Gene Therapy for Painful Diabetic Neuropathy — Completed
• Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy — Completed
• Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy — Completed
• Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS — Stopped early
• Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis — Running, not enrolling
• Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy — Completed
• Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial — Stopped early
• Study of Arimoclomol in Inclusion Body Myositis (IBM) — Completed
• Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS — Completed
• A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy — Completed
• A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN) — Completed
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy — Completed
• Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy — Completed
• Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy — Completed